Rydar Equities’s Atossa Therapeutics ATOS Stock Holding History

Rydar Equities’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$819	Buy	+333	New	+$793	﹤0.01%	419

Other funds holding ATOS

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Rydar Equities's ATOS Position: Q3 2026 in Review

Rydar Equities opened a new position in Atossa Therapeutics (ATOS) in Q3 2026: 333 shares worth $819. The stake represents ﹤0.01% of the portfolio and ranks #419 among its holdings.

3 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.

Rydar Equities held 333 shares of Atossa Therapeutics worth $819 as of Q3 2026.
Atossa Therapeutics was a new Rydar Equities position in Q3 2026.
Atossa Therapeutics made up ﹤0.01% of Rydar Equities's portfolio in Q3 2026, its #419 holding.
3 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.